Mackenzie Financial
AMED

Mackenzie Financial’s Amedisys AMED Stock Holding History

Mackenzie Financial’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-437,964
Closed -$39.8M – 1674
2024
Q4 		$39.8M Sell
437,964
-256,629
-37% -$23.6M 0.05% 243
2024
Q3 		$67M Sell
694,593
-50,909
-7% -$4.97M 0.09% 190
2024
Q2 		$68.4M Sell
745,502
-11,968
-2% -$1.11M 0.1% 176
2024
Q1 		$69.8M Sell
757,470
-120,277
-14% -$11.3M 0.1% 175
2023
Q4 		$83.4M Sell
877,747
-63,311
-7% -$5.91M 0.13% 153
2023
Q3 		$88.4M Sell
941,058
-1,599
-0.2% -$148K 0.15% 140
2023
Q2 		$86.1M Sell
942,657
-98,923
-9% -$8.12M 0.13% 154
2023
Q1 		$76.6M Buy
1,041,580
+438
+0% +$37.9K 0.12% 166
2022
Q4 		$87M Buy
1,041,142
+38,517
+4% +$3.47M 0.15% 155
2022
Q3 		$97M Sell
1,002,625
-1,730
-0.2% -$206K 0.17% 143
2022
Q2 		$7.38M Buy
1,004,355
+47,575
+5% +$6.08M 0.01% 485
2022
Q1 		$165M Buy
956,780
+386,411
+68% +$57.7M 0.22% 114
2021
Q4 		$92.3M Buy
570,369
+568,919
+39,236% +$91.4M 0.12% 171
2021
Q3 		$216K Sell
1,450
-626
-30% -$130K ﹤0.01% 1286
2021
Q2 		$508K Buy
2,076
+98
+5% +$25.7K ﹤0.01% 977
2021
Q1 		$524K Sell
1,978
-564
-22% -$159K ﹤0.01% 906
2020
Q4 		$746K Sell
2,542
-61
-2% -$15.6K ﹤0.01% 756
2020
Q3 		$615K Buy
2,603
+3
+0.1% +$682 ﹤0.01% 753
2020
Q2 		$516K Sell
2,600
-1,100
-30% -$205K ﹤0.01% 785
2020
Q1 		$679K Sell
3,700
-650
-15% -$116K ﹤0.01% 747
2019
Q4 		$726K Sell
4,350
-20,430
-82% -$3.04M ﹤0.01% 790
2019
Q3 		$3.25M Hold
24,780
– – 0.01% 530
2019
Q2 		$3.01M Sell
24,780
-8,255
-25% -$980K 0.01% 547
2019
Q1 		$4.07M Buy
33,035
+22,790
+222% +$2.86M 0.01% 591
2018
Q4 		$1.2M Buy
+10,245
New +$1.21M ﹤0.01% 781

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Mackenzie Financial's AMED Position: Q1 2025 in Review

Mackenzie Financial sold out of Amedisys (AMED) in Q1 2025, closing a stake of 437,964 shares — an estimated $39.8M sold.

Mackenzie Financial first reported a position in AMED in Q4 2018 and held it in 25 quarters. The position peaked at $165M in Q1 2022. 305 funds tracked by Wall St. Rank hold AMED as of Q1 2025.

  • Mackenzie Financial reported no remaining Amedisys position as of Q1 2025 after selling out during the quarter.
  • Mackenzie Financial sold 437,964 Amedisys shares in Q1 2025, an estimated $39.8M.
  • Mackenzie Financial first reported a position in Amedisys in Q4 2018 and held it in 25 quarters.
  • Mackenzie Financial's Amedisys position peaked at $165M in Q1 2022.
  • 305 funds tracked by Wall St. Rank held Amedisys as of Q1 2025.

Based on Mackenzie Financial's 13F filing for Q1 2025, filed 7 May 2025.